Mok T, Nakagawa K, Park K, Ohe Y, et al. Nivolumab Plus Chemotherapy in Epidermal Growth Factor Receptor-Mutated Metastatic Non-Small-Cell Lung Cancer After Disease Progression on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Final Results of CheckMate 722. J Clin Oncol 2024 Jan 22:JCO2301017. doi: 10.1200/JCO.23.01017.
PMID: 38252907